|
Last year was a pivotal year for global health. While the emergency phase of the COVID-19 pandemic began winding down, momentum for greater local production of vaccines, medicines, and diagnostic continued to build.
And, the results translated into more equitable access of medical products for millions of people worldwide.
Through our global health programs, we fostered swifter regulatory approvals of lifesaving medicines, produced more quality medicines in more places, and expanded workforce capacity to promote safe, effective, and quality-assured medical products.
| 
